Enzalutamide for prostate cancer

被引：0
|
作者：
Tanday, Sanjay
机构：
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 10期
关键词：
D O I：
10.1016/S1470-2045(12)70384-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E413 / E413
页数：1
相关论文
共 50 条
  • [1] Enzalutamide in Prostate Cancer, A Review on Enzalutamide and cancer
    Erdogan, Bulent
    Kostek, Osman
    Bekirhacioglu, Muhammet
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2018, 2 (03): : 121 - 129
  • [2] Enzalutamide for the treatment of prostate cancer
    Pal, Sumanta K.
    Stein, Cy A.
    Sartor, Oliver
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (05) : 679 - 685
  • [3] Enzalutamide in Metastatic Prostate Cancer
    Yin, Ming
    Vinh-Hung, Vincent
    Verschraegen, Claire
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (15): : 1493 - 1494
  • [4] PROSTATE CANCER The best fit for enzalutamide in metastatic prostate cancer
    Pal, Sumanta K.
    Sartor, Oliver
    NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (09) : 504 - 506
  • [5] Enzalutamide in castration resistant prostate cancer
    Rios Gonzalez, Emilio
    Martinez-Pineiro, Luis
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (08): : 664 - 675
  • [6] An update on enzalutamide in the treatment of prostate cancer
    Merseburger, Axel S.
    Haas, Gabriel P.
    von Klot, Christoph-A.
    THERAPEUTIC ADVANCES IN UROLOGY, 2015, 7 (01) : 9 - 21
  • [7] Enzalutamide in systemic treatment of prostate cancer
    Zolnierek, Jakub
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (06): : 303 - 309
  • [8] Enzalutamide in Biochemically Recurrent Prostate Cancer
    Pollak, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (01): : 90 - 90
  • [9] Enzalutamide and metastasis risk in prostate cancer
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (08): : E387 - E387
  • [10] Enzalutamide in Prostate Cancer after Chemotherapy
    Berruti, Alfredo
    Generali, Daniele
    Tampellini, Marco
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2448 - 2448
12345